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Background
Cardiovascular disease and dysfunction (CVD) are leading causes of Intensive Care Unit 
(ICU) admission and mortality worldwide. CVD was responsible for 31% of global deaths 
in 2013, and the estimated worldwide cost associated with CVD in 2010 was $863 billion 
USD, accounting for approximately 1.39% of gross world product in the same year [1]. 
Despite the need with aging populations for optimised cardiovascular care in the ICU, 
inadequate or incorrect diagnosis of cardiac disturbances resulting in increased length 
of stay, cost and mortality is an ongoing issue [2, 3]. Cardiac management in the ICU 
is often informed by measurements taken from catheters placed near the heart. How-
ever, despite the rich information available from such catheter waveforms, their use is 
not necessarily associated with improved clinical outcomes [4, 5]. Hence, improvement 
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in the extraction of cardiac information from these catheter waveforms has the potential 
to yield value from readily available data that has potentially been under-utilised to date.
Time varying elastance (TVE) is an important means of expressing internal cardiac 
dynamics and function [6]. The TVE curve represents the active elastance changes in 
the ventricles that drive heart contraction, thus providing valuable intra-beat informa-
tion about cardiac behaviour and energetics [6–8]. The TVE curve has a wide range of 
potential applications. It is often employed as an input in large cardiovascular models 
that seek to model the entire circulatory system [9–13], and also frequently used in the 
determining of important cardiac metrics, such as the end-systolic pressure–volume 
relation (ESPVR) [7].
There has been more limited investigation into the utility of the TVE curve in isolation. 
The area under the curve of the TVE curve is analogous to work done by the ventricle. It 
is thus a potentially significant indicator of patient condition. However, the typical nor-
malisation of the TVE curve means only relative changes in work for a given inotropic 
state can be compared. The TVE curve relies on a combination of ventricular pressure 
and volume waveforms similar to pressure–volume (P–V) loops. It thus contains infor-
mation concerning cardiac work [14, 15] and contractility [6, 16], both of which change 
in response to cardiac dysfunction. As such, it has been suggested that the shape of the 
ventricular elastance curve itself may have diagnostic use [17–19].
Unfortunately, the TVE curve can only be directly measured by placing catheters into 
the heart chambers, which is, understandably, not common practice. As such, the tradi-
tional approach to non-invasively generate a TVE curve is to fix it to a population based 
waveform [7, 11, 12]. Most existing work surrounding TVE curves is focused on using 
the TVE curve to estimate a clinical parameter, such as ejection fraction [20], and, most 
commonly, end-systolic elastance [7, 21, 22]. However, these studies are validated on 
correlations with the derived parameter, rather than on the shape and change in shape of 
the TVE curve itself. Thus, these approaches are not validated for use as part of a larger 
model of cardiac dynamics, or for direct use as a diagnostic aid.
Previous work specifically focused on experimentally generating a TVE curve and vali-
dating it based on its correlation with the analytically derived function showed prom-
ise, and noted changes in the TVE curves during pulmonary embolism and septic shock 
[17]. However, this work was limited by the availability of data for validation and the 
reliance on an assumed driver shape [17, 18]. Work has also been undertaken in mod-
elling time varying ventricular elastance, split into active and passive components, in 
humans [19]. Active elastance was shown to compare well with other metrics of con-
tractility, and the properties of these elastance curves were shown to change for different 
disease states. However, this method required highly invasive ventricular catheterisation 
and thus is not broadly implementable in a clinical environment. Hence, there is a sig-
nificant gap created by the current clinical inability to directly measure or estimate the 
TVE curve every beat.
This paper presents a novel, minimally invasive method for deriving the TVE curve 
beat-by-beat. The method focuses on combining simple physiological assumptions with 
clinically available catheter waveforms to individually simulate the pressure and volume 
components that define the TVE curve, rather than generating the TVE curve itself. 
Importantly, this approach avoids the need to directly assume a shape for the TVE curve, 
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and is thus better equipped to capture variations in this shape over time and condition, 
as well as the corresponding alterations in intra-beat cardiac behaviour.
Clinically feasible measurements mean the method has the potential for real-time 
implementation at the patient bedside, without requiring additional, invasive instru-
mentation. Such a TVE curve could be used to provide additional, patient specific infor-
mation on intra-beat behaviour and inter-beat variation in the functioning of the heart. 
Finally, monitoring the driver’s evolution over time could add significant new data and 
insight to improve diagnosis and treatment.
Methods
Proposed method
The TVE curve is defined:
where Plv is the pressure in the left ventricle, Vlv is the volume in the left ventricle and Vd 
is the ‘dead space’ volume in the ventricle [6, 23]. Thus, the TVE curve is defined by two 
waveforms (Plv and Vlv) and one constant (Vd). These values can be measured directly, 
but doing so is not clinically feasible [24].
The proposed method approximates these waveforms (Vlv, Plv) and constant (Vd) using 
three inputs, as shown in Fig. 1. These inputs include continuously sampled aortic pres-
sure waveforms (Pao) and heart rate (HR), data which is typically available in a mod-
ern ICU. The final input required is baseline end-systolic (Ves) and end-diastolic (Ved) 
(1)e(t) = Plv(t)
Vlv(t)− Vd
Fig. 1 Flowchart of the proposed method. Roman numerals indicate different method regions
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Volume, obtained from a brief echocardiography reading, which is increasingly available 
in a clinical setting [25].
The overall goal of this method is to use the clinically available inputs Pao, HR and 
baseline Ves and Ved to determine the outputs Plv, Vd and Vlv, and thus the TVE curve 
e(t) as set out in Fig. 1 and Eq. 1. This resulting TVE curve can be experimentally vali-
dated against the TVE curves derived from experimentally measured Plv and Vlv in ani-
mal models. The availability of a nearby continuous pressure measurement (Pao) forms 
an effective basis for the continuous approximation of Plv, and the availability of a base-
line volume measurement (Ves) forms an effective basis for the approximation of base-
line Vd. However, there is no continuous volume measurement available for continuous 
approximation of Vlv, resulting in this process being considerably more involved. Thus, 
the shaded central Region III in Fig. 1 is considerably more complicated than Regions I 
and II.
While the overall method involves approximating two output waveforms (Vlv, Plv) 
from a single input waveform (Pao), it’s important to note that all three waveforms (Plv, 
Vlv, Pao) have distinct features. Different regions of behaviour are governed by different 
physiological phenomenon, and these waveforms have been extensively characterised 
[26]. As such, all three waveforms are heavily interconnected and information rich, mak-
ing this task more reasonable than it might first appear.
Determining Plv from Pao (Region I, Fig. 1)
The left ventricle is situated directly upstream from the aorta, separated by the aortic 
valve. This valve is open during systole and closed during diastole. As such, if aortic 
valve resistance is neglected, Plv is equivalent to Pao, with a slight phase lag (δ) during 
the majority of systole (Section P. 1, Fig. 2). While aortic valve resistance is non-negli-
gible in conditions such as aortic stenosis [26], valve dysfunction of any type is present 
in only 3.61% of CVD mortalities in the US [27]. Further, such conditions are typically 
chronic in nature, relatively easily diagnosed [28] and evolve slowly, while the method is 



































Fig. 2 Simulating left ventricular pressure. Note Pao has been shifted left by δ to account for phase lag
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designed to monitor short term changes in an ICU environment. As such, this assump-
tion should not significantly affect the methods’ applicability to the vast majority of the 
target cohort.
During diastole the aortic valve is closed and little information is available from the 
aortic waveform about ventricular behaviour. However, the ventricle behaves in a largely 
passive manner in this region, meaning the TVE curve is typically near zero during dias-
tole [26]. As such, a generic function consisting of two exponentials was used to approxi-
mate left ventricular pressure during diastole. In early diastole (Section P. 2, Fig. 2) an 
exponential decay to a fixed baseline pressure captures ventricular relaxation. In late 
diastole-early systole (Section P. 3, Fig. 2), an exponential increase captures the begin-
ning of ventricular contraction [26].
While atrial contraction contributes significantly to late diastolic filling, ventricular 
elastance remains largely passive in late diastole [26]. Thus the TVE curve is typically at 
its baseline value until the beginning of ventricular contraction in early systole. While 
atrial function affects the magnitude of the driver function, which is normalised in this 
work, and may affect its shape, this effect is indirect as the driver function represents the 
impact of contraction in driving pulsatile blood from the heart to the arterial system. 
Further, with the increasing unpopularity of pulmonary artery catheters [29] none of the 
typically available instrumentation in an ICU provides a clear picture of atrial behaviour. 
As such, while the exponential in section P. 3 is broadly intended to capture ventricular 
filling, no specific atrial behaviour component is integrated into this model.
Using Fig. 2, the left ventricular pressure for the nth heartbeat is thus defined using Pao:
where: δ = 0.008s
Determining Vd from baseline Ves (Region II, Fig. 1)
A recent method has been developed to approximate Vd from ventricular volume meas-
urements [30]. This approach relies on linear regression of the Frank-Starling curve (SV–
Ved) and its end-systolic equivalent (SV–Ves) to the point where SV = 0 and ‘the ventricle 
cannot develop any systolic pressure’, the definition of Vd [23]. This work also showed 























Pao(t1 + δ < t < t2 + δ) t1 < t < t2
6+ (Pao(t2)− 6)e
−17.5(t−t2) t2 < t < t3
Plv(t3)+ (Pao(t4)− Plv(t3))e
37.5(t−t4) t3 < t < t4


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Vd as a percentage of baseline Ves allows approximation of baseline Vd during the initial 
echocardiographic reading where measured Ves is available. While Vd has been shown 
to change with condition, there is no practical means of capturing this change short of 
additional echocardiography measurements. Thus, while intermittent measures are fea-
sible, in this study Vd is fixed at a baseline value.
Determining Vlv from Pao, HR and Vd (Region III, Fig. 1)
Unlike pressure, little volume or flow information is readily available from the typical, 
clinically available instrumentation. Simulating Vlv is thus more challenging. The shape 
of the ventricular volume waveform was approximated by a piecewise sine wave con-
sisting of two sections: systole (Section V. 1, Fig. 3) and diastole (Section V. 2, Fig. 3), 
with a 90° phase shift at the beginning of systole. The underlying physiological behaviour 
might be better represented by a series of exponentials [26]. However, using sine waves 
achieves a similar result with considerably fewer variables involved.
Thus, six points per heartbeat (t1, t2, t3 and (Ved)n, (Ves)n, (Ved)n+1) are required to 
define the ventricular volume waveform. The timing associated with systole start (t1), 
systole end (t2), and diastole end (t3) are readily determined from the aortic pressure 
waveform (Fig. 3):
Using existing work [31] SV can be approximated beat-to-beat using the aortic wave-
form. Thus, only one of Ves or Ved is required, as SV can be used to convert between the 
two. The ESPVR allows for determination of Ves, and is defined [23]:









































Fig. 3 Simulating left ventricular volume
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where Ees is the end-systolic elastance and V0 is the ventricular volume at zero pressure. 
Equation 6 can be rewritten:
where this change is justified by:
  • The pressures in the ventricle and aorta are roughly equivalent until the aortic valve 
closes, thus PDN is close to Pes
  • Vd and V0 have similar, but distinct, physiological significance and values. The two 
are often used interchangeably [17, 18, 23]
Finally, it is necessary to account for Ees, which changes in response to a number of fac-
tors including contractility [6], and loading conditions [32, 33]. Thus, Eq. 7 is modified:
here Ees is defined as a function of HR and a coefficient (EC), with a cubic selected as 
it provides the best compromise between simplicity and effective tracking for the data 
set presented here. In particular, the cardiovascular system responds to most changes in 
conditions in a number of ways, including changes in heart rate and elastance. As heart 
rate is easily measured, it provides an easy to obtain, if incomplete, indication of cardio-
vascular system response, which can be used to inform an approximated elastance [34]. 
Further supporting evidence is provided in the validation and discussion of results.
During the echocardiography calibration, measurements for PDN, HR and Ves are avail-
able [35]. Thus, using Eq. 8, a constant value for EC can be defined, allowing approxi-
mation of Ees and thus determination of Ves on a beat-by-beat basis. The beat-to-beat 
ventricular volume can thus be determined:
where:
Summary of proposed method
The overall derivation of the TVE curve can be summarised:
Initially or intermittently
1. Calculate Vd using Eq. 4 and baseline Ves (Region I, Fig. 1)
2. Calculate EC using Eq. 8, PDN, HR and baseline Ves (Region III, Fig. 1)
(6)Pes = Ees × (Ves − V0)








































(11)Ved = Ves + SV
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Every heartbeat
1. Simulate Plv using Eq. 2, Eq. 3 and Pao (Region II, Fig. 1)
2. Determine Ves using Eq. 10, PDN, HR and EC (Region III, Fig. 1)
3. Determine SV using [31] and Pao (Region III, Fig. 1)
4. Determine Ved using Eq. 11, Ves and SV (Region III, Fig. 1)
5. Simulate Vlv using Eq. 5, Eq. 9, Pao, Ves and Ved (Region III, Fig. 1)
6. Calculate and normalise the TVE curve e(t) using Eq. 1
Analysis and validation
The proposed method was validated on experimentally gathered data. A range of input 
(Pao) and output (Vlv, Plv) waveforms were continuously measured via catheter. This data 
allowed validation of individual model assumptions through comparison with directly 
measured output waveforms, as well as validation of the overall method through com-
parisons between the TVE curve as calculated using simulated and directly measured Vlv 
and Plv wave forms.
The data set encompasses 46,318 heartbeats across 5 Piétrain pigs. A diverse clinical 
protocol provides the ability to assess intra- and inter-subject variability across a large 
amount of invasive and non-invasive measurements. Together they enable rigorous 
assessment and validation of the method.
Experimental procedure
The experimental protocol was approved by the Ethics Commission for the Use of Ani-
mals at the University of Liège, Belgium. Five male, pure Piétrain pigs weighing between 
18.5 and 29 kg were sedated, anaesthetised and mechanically ventilated (GE Engstrom 
CareStation) with a baseline positive end-expiratory pressure (PEEP) of 5  cmH2O (Fig. 4, 
Additional file  1: Table S1). Proximal aortic pressure was continually sampled using 
a pressure catheter (Transonic, NY, USA) with a sampling rate of 250  Hz. To provide 
direct measurements of Plv and Vlv for validation, the heart was accessed via a median 
sternotomy, and an admittance pressure–volume catheter (Transonic, NY, USA) with a 
sampling rate of 250 Hz inserted into the left ventricle via an apical stab [36, 37].
Fig. 4 The fully instrumented Piétrain Pig. The catheters for measuring Pao, Plv and Vlv are positioned to the 
left of the image
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To demonstrate a diverse range of cardiac states, several procedures were performed:
  • A single infusion of endotoxin (lipopolysaccharide from E. Coli, 0.5 mg/kg injected 
over 30 min) to induce septic shock. Septic shock drives a change in afterload con-
ditions and is associated with a large variety of effects including an inflammatory 
response and capillary leakage that may lead to hypovolemia, decreased cardiac out-
put, decreased ejection fraction and cardiac failure [38].
  • Several PEEP driven recruitment manoeuvres (RMs), both pre- and post-endotoxin 
infusion. RMs drive a change in preload conditions and are typically associated with 
a decrease in mean blood pressure and cardiac output [39].
  • One to four infusions of 500 mL saline solution over 30 min, pre- and post-endotoxin 
infusion, simulating fluid resuscitation therapy, a key component of hemodynamic 
resuscitation in patients with severe sepsis, which itself results in a change in circula-
tory volume [40].
Validation of significant model assumptions
Two major assumptions made in deriving this model are:
1. That Vd can be expressed as a function of baseline Ves, as in Eq. 4
2. That Ees can be expressed as a function of HR, as in Eq. 8
Direct evaluation of the tracking of Ves using different forms of ESPVR allows valida-
tion of both of these assumptions. In particular, 3 different methods of tracking Ves were 
compared:
1. Fixed Ees and neglected V0: The standard ESPVR (Eq. 6) with V0 = 0 (a commonly 
used assumption [17, 18, 23])
2. Fixed Ees and fixed V0: The standard ESPVR (Eq. 7) with V0 = Vd (allowing assess-
ment of the validity of Eq. 4)
3. Dynamic Ees and fixed V0: The ESPVR as used in the proposed method (Eq. 8) with 
V0 = Vd, and Ees as a function of HR (allowing assessment of the validity of Eq. 8)
Validation of overall model
The overall method presented here is designed to simulate the TVE curve beat-by-beat, 
without requiring invasive instrumentation of the heart or real-time image-based moni-
toring, neither of which is clinically or ethically feasible in care. As such, validation of 
the method relies on comparison of the simulated TVE curve to the invasively measured, 
‘true’ TVE curve, which is calculated using the catheter measured Vlv and Plv waveforms 
for a single beat. This comparison is achieved by calculating the absolute and signed ‘error 
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where εsim and εmeas are the simulated and measured TVE curves respectively, t is nor-
malised time set to 1 for every heart beat to enable comparison over different beats, and 
εabs and εsgn and denote the absolute and signed errors respectively. An example TVE 
curve with an absolute error of 7.8% and bias of −3.4% is shown in Fig. 5, where shading 
denotes the error area.
Results
Validation of significant model assumptions
Table 1 shows the percentage error associated with the 3 methods specified to track Ves. 
Moving from neglected V0 (Method 1) to fixed V0 (Method 2), via Eq. 4, shows a modest 
reduction in median and 25th percentile errors (15.9–14.5% and 3.1–1.3%, respectively), 
but a highly significant reduction in 75th percentile error (43.2–25.5%). Introduction 
of dynamic Ees (Method 3) as opposed to fixed Ees (Method 2), via Eq. 8, shows a very 
significant reduction in median and 75th percentile errors (14.5–4.3% and 25.5–15.0%, 
respectively). These results support the validity and usefulness of Eqs.  4 and 8, their 
associated assumptions in the tracking of Ves, and thus the use of Method 3 in the overall 
approximation of the TVE curve.


























Fig. 5 Example TVE curve error. This simulated driver has an error of 7.8% and bias of −3.4%
Table 1 Absolute percentage error associated with different methods of tracking  Ves
Pig 1. Fixed Ees, neglected V0 2. Fixed Ees, fixed V0 3. Dynamic Ees, fixed V0
25th 
Perc. (%)








Med (%) 75th Perc. 
(%)
Pig 1 0.7 4.6 23.9 0.6 8.7 14.7 0.2 1.8 9.0
Pig 2 2.1 19.5 39.1 2.1 23.4 34.0 1.8 6.5 16.5
Pig 3 4.2 12.2 45.0 0.2 5.6 16.6 0.5 4.5 12.7
Pig 4 7.3 30.7 42.7 2.9 23.3 29.3 0.4 4.7 13.6
Pig 5 1.1 12.4 65.4 0.9 11.7 32.7 0.4 4.2 23.4
Mean 3.1 15.9 43.2 1.3 14.5 25.5 0.7 4.3 15.0
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Note the values quoted from the final row of Table 1 are an average of the 25th percen-
tile, median and 75th percentile error for the pigs rather than an overall 25th percentile, 
median and 75th percentile error. The decision was made to represent population values 
in this way as the overall median is less representative than the average median due a dif-
fering number of heartbeats recorded for different pigs.
The comparative behaviour of these 3 methods is well illustrated in Fig. 6, which shows 
the tracking of Ves for Pig 1. Method 1 agrees reasonably well with measured Ves dur-
ing normal behaviour, but diverges significantly from measured Ves during recruitment 
manoeuvres and the onset of severe sepsis, where there are large vertical changes in Ves. 
Method 2 accurately captures these large vertical changes in Ves, reducing the large 75th 
percentile error in Method 1. Method 3 retains the tracking of large vertical changes in 
Method 2, and tracks normal behaviour more effectively by accounting for changes in 
Ees, significantly reducing median error.
Validation of overall model
The overall purpose of this model is to track the shape of the TVE curve, and how this 
shape changes when circulatory behaviour changes. Table 2 shows the area under the 
curve errors, ϵabs and ϵsgn, for all 5 pigs. The median error is relatively small at 11.4%, 
Table 2 TVE curve percentage area under  the curve errors (εabs and  εsgn) associated 
with proposed method (identifying Ves and Ved)
Pig Absolute percentage error, εabs Signed percentage error, εsgn
25th Perc. Med 75th Perc. 25th Perc. Med 75th Perc.
Pig 1 9.0 11.6 14.4 −7.0 −4.9 −2.6
Pig 2 7.8 9.4 11.6 −1.4 2.3 6.6
Pig 3 9.4 11.4 15.6 −12.6 −7.8 −4.5
Pig 4 9.5 11.1 13.0 −9.3 −7.5 −5.7
Pig 5 10.5 13.4 19.0 −0.3 5.2 10.1
Mean 9.2 11.4 14.7 −6.1 −2.5 0.8

































Fig. 6 Tracking of Ves. Comparison between the three methods in 2.2.2 for Pig 1
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suggesting the method is effective, and the interquartile range relatively narrow at 
9.2–14.7%, suggesting the method is consistent. The bias is also small at −2.5%, with an 
interquartile range of −6.1 to 0.8%, suggesting only a slight method bias.
Table 3 shows, as a point of comparison, the area under the curve errors associated 
with the method if the directly measured values for Ves and Ved are used. Using these 
measured values removes the majority of Region III, Fig. 1 (Eqs. 4 and 6–11) from the 
overall method, where a lot of relatively significant assumptions are made. The errors 
in Table 3 are very comparable to those in Table 2, with an overall modest reduction in 
average median error (11.4–10.2%) and bias (−2.5 to −2.2%), as expected when measur-
ing Ves and Ved directly and invasively rather than estimating them. Hence, the assump-
tions made had very little impact on error when removed.
Figure 6 shows a variety of measured and modelled TVE curve shapes for each of the 
5 pigs, capturing both intra- and inter-subject variability. For each figure, Panel I shows a 
baseline waveform, Panel II a waveform during a RM and Panel III a waveform after endo-
toxin infusion has occurred and sepsis develops. The range of shapes and inter-pig varia-
bility indicated that assuming a generic population or cohort TVE curve is not particularly 
valid, and is further supported by the range of intra-pig variability evidenced. There are 
a variety of shoulder heights, relative gradient and maximum/minimum gradient timings 
that result in TVE curves with distinct shapes, variations which are well captured by the 
method. These TVE curves were also selected to demonstrate a range of error values simi-
lar to the interquartile error range for that pig (Table 2). Thus, these drivers are reasonably 
representative of the overall ability of the method to capture TVE curve shapes, despite 
different overall shapes for each pig and changes in shape as condition changes.
Discussion
Validation of significant model assumptions (Table 1)
A direct evaluation of the effectiveness of three different ESPVR equations set out in 
2.2.2 in tracking Ves allowed validation of the assumptions that:
  • That Vd can be derived from Ves as in Eq. 4 (implemented in Method 2)
  • That Ees can be expressed as a function of HR as in Eq. 8 (implemented in Method 3)
Method 1 serves as a control and uses a simplified ESPVR, assuming V0 = 0 and Ees 
is constant. This method tracks Ves reasonably well, yielding an overall median error of 
Table 3 TVE curve percentage area under  the curve error (εabs and  εsgn) associated 
with using measured Ves and Ved values
Pig Absolute percentage error, εabs Signed percentage error, εsgn
25th Perc. Med 75th Perc. 25th Perc. Med 75th Perc.
Pig 1 9.0 11.5 13.3 −8.1 −5.6 −2.7
Pig 2 7.3 8.5 10.1 −3.7 −0.7 2.2
Pig 3 7.1 8.1 9.1 −4.7 −2.7 −0.6
Pig 4 9.5 11.4 13.5 −9.9 −7.8 −5.6
Pig 5 9.8 11.3 13.5 2.8 6.0 9.0
Mean 8.5 10.2 11.9 −4.7 −2.2 0.5
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15.9% across all 5 pigs compared to Ves as directly measured. The assumption that V0 can 
be neglected is often used due to a combination of V0 being difficult to measure directly, 
as it requires a significant artificial reduction in ventricular pressure [41], and V0 typi-
cally being relatively small [42]. This assumption is largely supported by these results, as 
a 15.9% median error seems acceptable when weighed against the type of highly invasive 
and involved protocol traditionally required to determine V0.
However, as shown in Fig.  6, this 15.5% median error fails to capture the extremely 
large inaccuracies associated with using Method 1 to track sudden changes in Ves due, 
for example, to recruitment manoeuvres or the onset of severe sepsis. This failure to 
track sudden changes leads to a significantly larger 75th percentile error of 43.2% for 
Method 1. This high error when sudden changes occur is of concern in an ICU or car-
diac surgery clinical scenario, where sudden changes and accurate, rapid determination 
of patient responses to these sudden changes is extremely important [26].
Method 2 introduces the assumption that Vd can be derived from baseline Ves, as in 
Eq.  4, and that Vd can be used as a surrogate for V0. There is a minor, but important 
physiological distinction between the two values: V0 is the ventricular volume at 0 pres-
sure, while Vd is the volume at which the ventricle cannot develop any systolic pressure 
[23]. However, the purpose of both terms is to account for the subject-specific inactive 
volume within the ventricle, and the two values have been shown to be similar for a 
given subject [23].
Method 2 results in a notable decrease in 75th percentile error compared to Method 
1 (43.2–25.5%), and is able to track sudden changes in Ves significantly more effectively, 
as shown in Fig. 6. However, Method 2 yields only a modest reduction in median error 
compared to Method 1 (15.9–14.5%), as both methods fail to capture the dynamic 
nature of Ees. Thus, large errors are reduced, but overall accuracy is not greatly improved. 
Regardless, these results provide support for the validity of Eq. 4, and the use of Vd as 
a surrogate for V0 here. The fact that these reductions in error are sustained over sig-
nificant changes in cardiac output and ejection fraction as sepsis develops suggests that 
the absolute value of Vd does not change significantly enough under such conditions to 
detract from method accuracy.
Method 3 further assumes that Ees can be expressed as a function of HR. This assump-
tion is unusual, but is supported by the results. The full method sees a further, significant 
reduction in 75th percentile error compared to Methods 1 and 2 (43.2% and 25.5–15.0%, 
Table 1), and, most importantly, a very large reduction in median error compared to both 
Methods 1 and 2 (15.9% and 14.5–4.3%, Table 1). This result suggests general tracking of 
trends in Ves is being significantly improved, also supporting the validity of expressing 
Ees as a function of HR. This behaviour can also be observed in Fig. 6. This result, com-
bined with the minimal addition in method complexity required to include HR, which is 
very easy to measure, provides a strong case for the use of Method 3.
However, it is still important to note that the relationship between Ees and HR 
expressed in Eq. 8 is a significant simplification of actual cardiac behaviour. The cardiac 
system uses a large variety of responses to maintain cardiac output. The cubic used to 
approximate Ees changes as a function of HR attempts to mathematically approximate 
the sympathetic nature of some of these responses, but, inevitably, the relationship 
between HR and Ees varies between subjects (accounted for by calibration), and as time 
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and condition changes. While the cubic approximation of this relationship has been 
demonstrated to remain effective across the full progression of septic shock in the data 
presented here, further validation of this relationship, and especially the use of a cubic, 
across other conditions is desired.
Validation of overall model
Simulating the TVE curve using the proposed method resulted in a relatively low 
median absolute error area, ranging from 9.4 to 13.4% (Table  2) across all pigs. This 
narrow range of median absolute errors implies the method is able to consistently and 
effectively capture inter-subject variations in TVE curve behaviour, suggesting it is gen-
eralizable to other subjects. This inter-subject variability is demonstrated well by various 
baseline drivers shown in Fig. 7. All 5 pigs demonstrate relatively distinct baseline TVE 
curve shapes, showing a considerable level of inter-subject variability impossible to cap-
ture with a generic cohort or population based TVE curve that relies on a basic assumed 
shape [17, 18].
The simulated TVE curve also had a relatively narrow average interquartile error range 
of 9.2–14.7% (Table 2), suggesting the method is able to relatively consistently and effec-
tively capture inter-subject variations in TVE curve behaviour. This intra-subject vari-
ability, and inter-quartile error range, is illustrated in Fig. 7. Accurate capture of relative 
changes and trends in patient behaviour is extremely important, as these changes are 
critical in assessing whether a patient is recovering, responding to treatment, or is in 
need of a change in treatment. Most pigs demonstrated notable changes and intra-pig 
variability in driver shape during recruitment manoeuvres and as sepsis developed. A 
couple of the more unusual driver shapes were not fully captured, for example Panel 2 of 
Pig 4 in Fig. 7, where the driver measured driver displayed two peaks and the simulated 
driver only one.
The simulated TVE curve demonstrated consistently low signed area error, at −2.5% 
(IQR −6.1 to 0.8%), shown in Table 2. This result shows the method only slightly under-
estimating the TVE curve, supported further by 2 pigs having a slight positive bias 
and the other 3 a slight negative bias. This outcome further supports the ability of the 
TVE curve to accurately capture both intra- and inter-subject variability over time and 
condition.
In assessing the impact of assumptions on the TVE curve, a comparison of Table 2, 
using approximated Ves and Ved, and Table  3, using measured Ves and Ved, show very 
similar error values. For example, overall median error fell from 11.4 to 10.2% and over-
all bias from −2.5 to −2.2%, only a modest reduction in error. This implies that the body 
of assumptions and equations in Region III, Fig. 1 concerned with the approximating the 
Ves and Ved for simulation of Vlv do not result in a large increase in error compared to 
using measured Ves and Ved. The assumptions made in areas of the method not involv-
ing simulating Ves and Ved are relatively minimal, mostly involving using Pao to deter-
mine waveform timing. As such, it would seem that much of the error associated with 
this method is the result of the necessity of assuming equations for parts the two wave-
forms being reconstructed (Plv and Vlv), as shown in Figs. 2 and 3. Thus, the assumptions 
employed in Region III, Fig. 1 appear to function as intended, and further reduction in 
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error would probably require increased method complexity or an increase in the clini-
cally available data.
An important point to consider is the fact that the TVE curve is consistently normal-
ised to a duration and amplitude of 1.0, as it is designed specifically as an indicator of how 
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Fig. 7 Example TVE curves for each pig. A range of error values and cardiac states are shown
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metric (Ees) indicating the overall strength of that heartbeat [6, 17, 18]. This normalisation 
does mean that some of the errors associated with the various assumptions and approxi-
mations made throughout the method are negated, and that indicators of absolute cardiac 
work and its changes, for example, are not able to be directly extracted from the TVE 
curve created. Fortunately, the driver does not exist alone, the intent is that the shape of 
the TVE curve, indicative of transient, relative cardiac behaviour, be used alongside other 
existing metrics, such as Cardiac Output or Stroke Volume [31, 43], indicative of lumped, 
absolute cardiac behaviour, to provide further diagnostic information.
Limitations
There are study limitations that should be considered. First, all data presented is derived 
from a single protocol involving a single, but complex and varied [38], condition (sepsis). 
This data set encompasses several pigs, a full progression from healthy, baseline behaviour 
to cardiac failure and clinically standard ventilation and fluid interventions. Nevertheless, 
there is a much larger range of possible cardiac conditions, and further validation over sev-
eral of these would be beneficial. For example, the method would benefit from validation 
on contractility altering drugs such as dobutamine [44], which may alter the behaviour 
of the elastance term in Eq. 8. However, the method already detects changes in haemo-
dynamics, including those due to circulatory or cardiac muscle changes during sepsis in 
this study. Thus, the ability to detect changes due to inotropes should be similar to what is 
presented for the range of behaviours already observed in sepsis. Further, given inotrope 
infusions are determined and performed by a clinician, it would be possible to recalibrate 
the method directly after such an infusion to adjust to the new inotropic state if it proved 
necessary. Overall, the underlying physiology and data supporting the development of this 
method has been discussed in detail, and would be expected to generalise well to a wider 
range of conditions, as there are no intervention or condition specific assumptions made.
The method also requires validation on human subjects to ensure the methodology as 
presented here remains physiologically accurate, though the strong similarities between 
porcine and human physiology and the effectiveness of porcine models are well estab-
lished [45, 46]. Equally, only an animal model, as used here, allows the direct validation 
against cardiac measured PV loops, which would not be possible in humans. Thus, only 
an animal trial allows this important first validation.
The method does require an initial calibration via echocardiography or similar means. 
Echocardiography equipment is increasingly available in modern ICUs [25]. Further, 
echocardiography is non-invasive and the calibration period required is relatively short, 
requiring approximately 10 heartbeats. However, the requirement of such a calibration 
still prevents the method from being fully implementable without modest additional 
clinical workload using normal ICU instrumentation.
Conclusion
The TVE curve is an important, but difficult to clinically measure, expression of internal 
cardiac dynamics that captures the heart’s ability as a pump and can evolve over time, 
condition and patients. A novel, minimally invasive method for deriving the TVE curve 
beat-by-beat, by combining simple physiological assumptions with readily available cath-
eter waveforms to individually simulate the components of the TVE curve, is proposed. 
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This method was assessed across a cohort of 5 Piétrain pigs undergoing a progression 
from healthy behaviour to cardiac failure due to sepsis. The TVE curve generated by 
the method was shown to effectively track a directly measured function throughout the 
experiments, with low overall median absolute (11.4%) and signed (−2.5%) area under 
the curve errors. There is the potential for this method to provide real time, patient spe-
cific information on intra-beat behaviour and inter-beat variation in the heart, at the 
patient bedside, without requiring additional, invasive instrumentation.
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